Humana (NYSE:HUM) Shares Gap Down - Here's What Happened

Humana Inc. (NYSE:HUM - Get Free Report)'s share price gapped down prior to trading on Monday . The stock had previously closed at $288.12, but opened at $273.00. Humana shares last traded at $276.77, with a volume of 561,661 shares.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. TD Cowen raised their target price on Humana from $261.00 to $268.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. JPMorgan Chase & Co. lifted their price objective on Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a report on Wednesday, August 21st. Bank of America upgraded Humana from an "underperform" rating to a "neutral" rating and boosted their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. UBS Group dropped their price objective on Humana from $380.00 to $250.00 and set a "neutral" rating on the stock in a research note on Friday, October 4th. Finally, Truist Financial decreased their target price on Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a report on Friday, October 11th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $315.86.

Humana Trading Down 2.8 %

The firm's 50 day moving average is $289.38 and its 200 day moving average is $332.82. The company has a market cap of $33.74 billion, a PE ratio of 25.52, a PEG ratio of 2.28 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. On average, equities analysts anticipate that Humana Inc. will post 15.83 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.26%. Humana's payout ratio is 31.36%.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Pzena Investment Management LLC increased its position in Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock valued at $866,250,000 after purchasing an additional 1,955,375 shares during the period. Ontario Teachers Pension Plan Board grew its position in shares of Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider's stock worth $367,342,000 after buying an additional 1,050,459 shares during the period. Marshall Wace LLP grew its position in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock worth $532,564,000 after buying an additional 774,085 shares during the period. International Assets Investment Management LLC grew its position in shares of Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock worth $2,340,660,000 after buying an additional 738,701 shares during the period. Finally, Steadfast Capital Management LP purchased a new stake in shares of Humana in the 1st quarter worth about $158,813,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.